Clinical Trial Update: Single and Multiple Dose Study of Uprifosbuvir (MK-3682/IDX21437) in Healthy and Hepatitis C Virus (HCV)-Infected Participants (MK-3682-001) [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 clinical trial evaluating single and multiple doses of Uprifosbuvir in healthy participants and those with chronic hepatitis C; completed with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis C

Drugs mentioned

• Uprifosbuvir (uprifosbuvir)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Chronic Hepatitis C | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2018-09-13